The provision of quality drug treatment at affordable prices to all people across the globe in a manner that supports sustainability.

About Us

MEDOCHEMIE was established in 1976 in Cyprus by Dr. Andreas Pittas. The journey has seen our active expansion into promising markets across the world – from our base in Europe, to the Middle East & Africa, through to the Far East and the Americas. Outside our 20 core offices, we developed a network of trusted agents and partners allowing us to operate in 107 countries.

Today, Medochemie Ltd has thirteen manufacturing plants and facilities. Nine are in Cyprus, one in the Netherlands, and three in Vietnam. We have acquired and maintain 3,800 marketing authorisation licences for 630 different pharmaceutical products, classified in over 10 therapeutic categories. We operate in accordance with the strictest quality standards and in full compliance with European guidelines.

The driving force behind Medochemie is our 1370 multinational, talented, quality-focused employees, who work in our manufacturing plants and offices worldwide. Medochemie is a founding member of the Medicines for Europe (former EGA).